Demser approved in Japan to improve catecholamine excess secretion in patients with pheochromocytoma Jan. 9, 2019
Spero and Everest Medicines sign license and option agreements for SPR-206 and SPR-741 in Asia Jan. 9, 2019
CX-23, an NQO1-selective activated prodrug of triptolide, shows promise in preclinical models of HCC Jan. 9, 2019
RSS